Breaking News Instant updates and real-time market news.

PRTK

Paratek Pharmaceuticals

$10.55

-0.35 (-3.21%)

09:14
08/09/18
08/09
09:14
08/09/18
09:14

Tone of Paratek advisory committee meeting 'extremely positive,' says Wedbush

Wedbush analyst Robert Driscoll said the tone of yesterday's antimicrobials drug advisory committee meeting was "extremely positive" regarding to the data presented by Paratek and he expects full approval of omadacycline for the treatment of both acute bacterial skin infections and community-acquired bacterial pneumonia in early October. He believes the flexible dosing, low risk of C. difficile and lack of drug-drug interactions will support significant commercial success of omadacycline. Driscoll keeps an Outperform rating and $20 price target on Paratek shares.

  • 14

    Aug

PRTK Paratek Pharmaceuticals
$10.55

-0.35 (-3.21%)

04/06/18
CANT
04/06/18
NO CHANGE
Target $50
CANT
Overweight
Paratek Pharmaceuticals shares remain undervalued, says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen said yesterday afternoon that shares of Paratek Pharmaceuticals remain undervalued with potential approval of omadacycline and Seysara. The FDA's acceptance of the company's omadacycline new drug application for priority review is in line with expectations, Chen tells investors in a research note. She keeps an Overweight rating on the shares with a $50 price target.
08/06/18
HCWC
08/06/18
NO CHANGE
Target $55
HCWC
Buy
Paratek risk/reward favorable into Wednesday's panel, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce believes the risk/reward for Paratek Pharmaceuticals is "positively-skewed" into Wednesday's FDA panel meeting for omadacycline. The analyst expects a "relatively smooth" panel and would be buyers of the stock heading into the early October FDA action date. Arce keeps a Buy rating on Paratek with a $55 price target.
08/08/18
RAJA
08/08/18
NO CHANGE
RAJA
Outperform
AdCom vote increases chances of Paratek's omadacycline approval, says Raymond James
Raymond James analyst Laura Chico notes that the FDA's Advisory Committee voted 17-1 in favor of approval for Paratek Pharmaceuticals' omadacycline in skin infections and 14-4 in favor of approval in pneumonia. While the analyst acknowledges that the FDA is not bound by the committee's decision, they nearly always follow the recommendation. Thus, she thinks the vote incrementally increases the chances for an omadacycline approval. Chico reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

JD

JD.com

$24.23

-0.45 (-1.82%)

11:25
02/21/19
02/21
11:25
02/21/19
11:25
Options
JD.com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 04

    Mar

  • 20

    Mar

KMTUY

Komatsu

$0.00

(0.00%)

11:21
02/21/19
02/21
11:21
02/21/19
11:21
Downgrade
Komatsu rating change  »

Komatsu downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:20
02/21/19
02/21
11:20
02/21/19
11:20
General news
Treasury announced $113 B in shorter dated coupon sales for next week »

Treasury announced $113 B…

SCI

Service Corp.

$42.31

-0.42 (-0.98%)

11:17
02/21/19
02/21
11:17
02/21/19
11:17
Hot Stocks
Service Corp. raises quarterly cash dividend 6% to 18c per share »

Service Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
02/21/19
02/21
11:17
02/21/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
02/21/19
02/21
11:16
02/21/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
02/21/19
02/21
11:15
02/21/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
02/21/19
02/21
11:15
02/21/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

GS

Goldman Sachs

$197.12

-1.49 (-0.75%)

11:10
02/21/19
02/21
11:10
02/21/19
11:10
Initiation
Goldman Sachs initiated  »

Odeon's Dick Bove…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 03

    Mar

  • 12

    Mar

11:10
02/21/19
02/21
11:10
02/21/19
11:10
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

DK

Delek US

$36.95

-0.13 (-0.35%)

11:10
02/21/19
02/21
11:10
02/21/19
11:10
Options
Delek US draws upside call buyers as shares slip off early highs »

Delek US draws upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
02/21/19
02/21
11:10
02/21/19
11:10
General news
Existing home sales fell 1.2% in January to 4.99 M, a 3-year low »

Existing home sales fell…

11:08
02/21/19
02/21
11:08
02/21/19
11:08
General news
3-Month Bill Announcement CUSIP Number data reported »

3-Month Bill Announcement…

MNST

Monster Beverage

$58.64

-0.07 (-0.12%)

11:07
02/21/19
02/21
11:07
02/21/19
11:07
Options
Monster Beverage option volume spikes to 3X daily average amid active trading »

Monster Beverage option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

LIVN

LivaNova

$98.56

-1.32 (-1.32%)

11:07
02/21/19
02/21
11:07
02/21/19
11:07
Recommendations
LivaNova analyst commentary  »

Piper says Japanese…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

  • 07

    May

  • 08

    May

  • 09

    May

UBCP

United Bancorp

$10.95

(0.00%)

11:04
02/21/19
02/21
11:04
02/21/19
11:04
Hot Stocks
United Bancorp raises quarterly cash dividend to 13.25c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LIVN

LivaNova

$98.59

-1.29 (-1.29%)

11:03
02/21/19
02/21
11:03
02/21/19
11:03
Hot Stocks
LivaNova announces national reimbursement in Japan for Perceval valve for AVD »

LivaNova announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

  • 07

    May

  • 08

    May

  • 09

    May

KO

Coca-Cola

$45.48

0.36 (0.80%)

11:03
02/21/19
02/21
11:03
02/21/19
11:03
Hot Stocks
Coca-Cola announces new share repurchase program for up to 150M shares »

The Coca-Cola board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 03

    Mar

KO

Coca-Cola

$45.49

0.37 (0.82%)

11:02
02/21/19
02/21
11:02
02/21/19
11:02
Hot Stocks
Coca-Cola raises quarterly dividend to 40c per share from 39c per share »

The Coca-Cola board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 03

    Mar

11:00
02/21/19
02/21
11:00
02/21/19
11:00
General news
EIA natural gas storage change for week ending February 15 »

Earlier, gas inventories…

11:00
02/21/19
02/21
11:00
02/21/19
11:00
General news
Crude inventories for week of February 15 »

Crude oil inventories…

KR

Kroger

$28.82

0.07 (0.24%)

11:00
02/21/19
02/21
11:00
02/21/19
11:00
Options
One-day call buyers in Kroger »

One-day call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 07

    Mar

UAA

Under Armour

$21.26

-0.02 (-0.09%)

, UA

Under Armour

$19.22

0.025 (0.13%)

10:52
02/21/19
02/21
10:52
02/21/19
10:52
Periodicals
Under Armour CEO questioned by board about ties with MSNBC anchor, WSJ says »

A number of current and…

UAA

Under Armour

$21.26

-0.02 (-0.09%)

UA

Under Armour

$19.22

0.025 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

10:50
02/21/19
02/21
10:50
02/21/19
10:50
General news
U.S. corporate bond update: issuance continues apace today »

U.S. corporate bond…

COUP

Coupa Software

$92.39

-1.36 (-1.45%)

10:50
02/21/19
02/21
10:50
02/21/19
10:50
Options
Short-term hedge opened in Coupa Software »

Short-term hedge opened…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 12

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.